There are hopes cheap and widely available drug aspirin could boost immunotherapy in patients with triple negative breast cancer as an 'exciting' trial beginsAspirin is being trialled as part of a potential new treatment for an aggressive form of breast cancer. Researchers hope the cheap and common drug could work safely with immunotherapy in patients with triple negative breast cancer, which disproportionately affects younger women. Funded by charity Breast Cancer Now, it will initially recruit 42 patients from the Christie in Manchester. If successful it could be tried on incurable secondary triple negative breast cancer, in which cancer cells have spread to other parts of the body. Dr Simon Vincent, director at Breast Cancer Now, said: “The 8,000 women diagnosed with triple negative breast cancer in the UK each year face the frightening reality of limited treatment.

Source: Daily Mirror August 17, 2021 23:00 UTC